Friedrich-Alexander University (FAU) Erlangen-Nuremberg, Department of Pharmaceutics, Freeze Drying Focus Group (FDFG), Cauerstrasse 4, 91058 Erlangen Germany; GILYOS GmbH, Friedrich-Bergius-Ring 15, 97076 Würzburg Germany.
GILYOS GmbH, Friedrich-Bergius-Ring 15, 97076 Würzburg Germany.
J Pharm Sci. 2020 Oct;109(10):3035-3044. doi: 10.1016/j.xphs.2020.06.025. Epub 2020 Jul 8.
This case study proposes a development strategy for the SynchroFreeze vacuum-induced surface freezing technology for challenging high fill volume model systems. Critical steps during the development of a nucleation protocol are discussed as an example approach for implementing vacuum-induced surface freezing for high fill volume products. Slow pressure ramps and hold steps at adequate pressures have been found to be crucial for avoiding defects caused by either excessive outgassing or incomplete degassing. The evaporative mass loss during the SynchroFreeze procedure is characterized and thermal gradients during nucleation for several model systems with concentrations in the 50-400 mg/mL range are analyzed. The technology results in a measurable mass loss that may be relevant for low fill volume formulations. Thermal data show a pronounced temperature gradient throughout the entire product solution during nucleation by vacuum-induced surface freezing. The formulation composition, concentration, and shelf temperature have been shown to influence this temperature gradient. Reliable nucleation was achieved for sucrose formulations with concentrations up to 200 mg/mL at shelf temperatures minimally below the equilibrium freezing point.
本案例研究提出了一种针对 SynchroFreeze 真空诱导表面冻结技术的开发策略,该技术适用于具有挑战性的高填充体积模型体系。以成核方案的开发为例,讨论了关键步骤,为高填充体积产品实施真空诱导表面冻结提供了一种方法。研究发现,缓慢的压力斜坡和在适当压力下保持步骤对于避免由于过度出气或不完全脱气引起的缺陷至关重要。SynchroFreeze 过程中的蒸发质量损失特征以及浓度在 50-400mg/mL 范围内的几种模型体系的成核过程中的热梯度都进行了分析。该技术会导致可测量的质量损失,这对于低填充体积配方可能是相关的。热数据显示,在通过真空诱导表面冻结进行成核期间,整个产品溶液中存在明显的温度梯度。制剂组成、浓度和货架温度已被证明会影响该温度梯度。在货架温度至少低于平衡冻结点的情况下,成功实现了浓度高达 200mg/mL 的蔗糖制剂的可靠成核。